Evidence map›Paper›PMID 31046482›Full record

ArticleIntegrative cancer therapies

Production Trends, Collaboration, and Main Topics of the Integrative and Complementary Oncology Research Area: A Bibliometric Analysis.

Jose A Moral-Munoz, Lidia Carballo-Costa, Enrique Herrera-Viedma, Manuel J Cobo

Abstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Tissue engineering in otorhinolaryngology: A knowledge-based analysis.Laryngoscope investigative otolaryngology · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Publication Trends in Rehabilitative Effects of Acupuncture: A Visual Analysis of the Literature.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jose A Moral-Munoz1 Department of Nursing and Physiotherapy, University of Cádiz, Cádiz, Spain.ORCID 0000-0002-6465-982X
Lidia Carballo-Costa3 Department of Physiotherapy, Medicine and Biomedical Sciences, University of A Coruña, Campus de A Coruña, A Coruña, Spain.
Enrique Herrera-Viedma4 Department of Computer Science and Artificial Intelligence, University of Granada, Granada, Spain.
Manuel J Cobo5 Department of Computer Science and Engineering, University of Cádiz, Cádiz, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of cancer has increased over time worldwide. Nevertheless, the number of deaths has been reduced during the past 2 decades. Thus, one-third of the cancer patients are users of complementary and alternative therapies, looking for other types of interventions. The main aim of the present study is to understand the current status of the research in integrative and complementary oncology. Three different aspects were analyzed: production trends, country collaboration, and leading research topics.

methodsThe dataset was obtained from the documents indexed under the Integrative and Complementary Medicine category of the Web of Science database from 1976 to 2017. VOSviewer and SciMAT software were employed to perform the bibliometric analysis.

resultsThe Journal of Ethnopharmacology, China Medical University and the People's Republic of China are the leading producers in the field. Regarding the collaboration, the United States and China present a close connection. The scientific community is focused on the following topics: apoptosis, breast cancer, oxidative stress, chemotherapy, and nuclear factor-Kappa-B (NF-Kappa-B).

conclusionsThe present article shows potentially important information that allows understanding of the past, present, and future of research in integrative and complementary oncology. It is a useful evidence-based framework on which to base future research actions and academic directions.

Indexed as

BibliometricsBiomedical ResearchComplementary TherapiesDatabases, FactualHumansMedical OncologyPrevalencealternative medicinebibliometricscomplementary oncologyintegrative medicineintegrative oncologyscientometrics

Identifiers

PMID31046482
PMCPMC6501486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.